As world’s leading experts in sensitive real-time PCR based assays for somatic mutations in cancer, PentaBase decided in March 2020 to become an active part in the fight against COVID-19 outbreak. Through a rapid effort of our researchers, we developed a sensitive and specific multiplex RT qPCR version of the COVID-19 test, CoviDetect™. The test is unique as it allows testing of three times as many samples, using the standard laboratory equipment.

PentaBase uses its knowledge and resources to help companies by providing a COVID-19 detection service

Once the COVID-19 test has been validated and approved by both Novo Nordisk and Rigshospitalet, PentaBase has also developed a COVID-19 service detection. Our service is designed for companies who want to secure their most important resource, the employees. By testing for COVID-19, companies can identify earlier the virus and thus, a chain of SARS-CoV-2 infection within the organisation can be prevented. 


Designed for companies

We help you to protect your employees while you continue to conduct business as usual. Through our COVID-19 testing, we can identify in real-time if any of your organisation member is infected. Whether they have travelled abroad or you simply want to ensure a safe work environment, PentaBase offers the solution customised for your needs. 

We guarantee the most secure way for COVID-19 testing. Using our technology, we are able to detect SARS-CoV-2 and any of its mutations. Our daily testing capacity is 1000 samples/day. The delivery time of the results are offered with 3 options; Express (within 4 hours), Same Day (Within the day), and Next Day (response next day).

If you are interested, please email us or sign up using the form below. We will process your request within 24 hours.

+45 36 96 94 96


1: Sample collection

COVID-19 test

A cotton swab is inserted into nostril to absorb secretions. The collected specimen is stored at 2-8° C for up to 72 hours or proceed to RNA extraction.

2: RNA Extraction


Purified RNA is extracted from the deactivated virus.

3: RT-qPCR

COVID19 test

Purified RNA us reverse transcribed to cDNA and amplified by qPCR.

4: Analysis

The real-time PCR technique is highly sensitive , specific and delivers the most reliable result.


The COVID-19 coronavirus disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and is an acute threat to global health. Using our technologies and knowledge, PentaBase is currently working on several initiatives to support healthcare workers, scientists and patients combating the COVID-19 disease.​

SARS-CoV-2 Oligonucleotides

PentaBase is a manufacturer of oligonucleotides based on standard and proprietary DNA technologies. We are currently supplying our customers with custom oligonucleotides for SARS-CoV-2 PCR assays based on our proprietary INA® technologies.
SARS-CoV-2 Assay

CoviDetect™ Test

By optimisation and combination of the three assays of the existing COVID-19 test panel, PentaBase has developed a sensitive and specific multiple version of the COVID-19 test. The multiplexed test is especially advantageous since it reduces the use of scarce plasticware and reagents, while it enables testing of three times as many samples using the same equipment.
Real-time PCR instrument

SARS-CoV-2 Instruments

We are supplying intruments and kits for detection of SARS-CoV-2, including our BasePurifier™ (Nucleic-Acid Extraction Instrument) and our Base Cycler™ (Real-Time PCR instrument).